INOVIO (NASDAQ: INO) announces inducement grant under Plan on Dec. 19, 2025, focusing on DNA medicines for HPV-related diseases and more.

Unusual Whales
2025.12.19 21:07
In a recent press release on December 19, 2025, based in Plymouth Meeting, Pennsylvania, the biotechnology firm INOVIO (NASDAQ: INO) unveiled their latest efforts in developing and distributing DNA medicines to combat HPV-related illnesses, cancer, and infectious diseases. The company, with a keen focus on creating innovative solutions, has disclosed significant progress in this mission.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer